CRXM Insider Trading Activity and SEC Form 4 Filings
CRXM insider trading summary
No open-market insider purchases or sales of Gene Biotherapeutics, Inc. (CRXM) have been reported on SEC Form 4 in the past 12 months.
Latest CRXM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 17, 2021 | Christopher J Jemapete | 10% Owner | Buy | $80K (200,000 @ $0.40) |
| Mar 16, 2021 | Christopher J Jemapete | 10% Owner | Buy | $12K (300,000 @ $0.04) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.